Home › Small Cell Lung Cancer › Indiana
Small Cell Lung Cancer clinical trials in Indiana
12 studies for Small Cell Lung Cancer are looking for participants at sites in Indiana.
Cities in Indiana
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Fort Wayne Medical Oncology And Hematology /ID# 277336, Fort Wayne
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07155174A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Franciscan St. Francis Health /ID# 279788, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Indiana University (IU) Health - Multi-D Oncology Clinic, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06712355A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Roudebush VA Medical Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05889546A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office, Fort Wayne
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07174583A Study of LY4175408 in Participants With Advanced Cancer
- Community Health Network, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07046923Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07153055MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT05903092Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 8, 2026 · NCT04919382Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06681220From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.